Longitudinal variations and predictors of increased perceived impact of multiple sclerosis, a two-year study

Journal of the Neurological Sciences

Volumn 270, Issue 1-2, 2008, Pages 53-59

  Ytterberg, Charlotte ^a   Johansson, Sverker ^a   Holmqvist, Lotta Widén ^a   Koch, Lena von ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Longitudinal; MSIS 29; Multiple sclerosis; Perceived impact; Predictors; Prospective

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; FATIGUE; FEMALE; FRIEDMAN TEST; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOOD; MULTIPLE SCLEROSIS; PERCEPTION; PHYSICAL DISEASE; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RATING SCALE; SCHOOL CHILD; STATISTICAL ANALYSIS; TIME;

ADULT; AGED; ANALYSIS OF VARIANCE; CHILD; COGNITION; CONFIDENCE INTERVALS; DISABILITY EVALUATION; EMOTIONS; FATIGUE; FEMALE; HUMANS; INTERNAL-EXTERNAL CONTROL; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; TIME FACTORS;

EID: 44649151158     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.01.014     Document Type: Article

References (42)

1. Visschedijk M.A., Uitdehaag B.M., Klein M., van der Ploeg E., Collette E.H., Vleugels L., et al. Value of health-related quality of life to predict disability course in multiple sclerosis. Neurology 63 (2004) 2046-2050
2. Rudick R.A., Miller D., Clough J.D., Gragg L.A., and Farmer R.G. Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol 49 (1992) 1237-1242
3. Nortvedt M.W., Riise T., Myhr K.M., and Nyland H.I. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology 53 (1999) 1098-1003
4. Amato M.P., Ponziani G., Rossi F., Liedl C.L., Stefanile C., and Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler 7 (2001) 340-344
5. Fruehwald S., Loeffler-Stastka H., Eher R., Saletu B., and Baumhackl U. Depression and quality of life in multiple sclerosis. Acta Neurol Scand 104 (2001) 257-261
6. Janardhan V., and Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci 205 (2002) 51-58
7. Benito-Leon J., Morales J.M., and Rivera-Navarro J. Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. Eur J Neurol 9 (2002) 497-502
8. Lobentanz I.S., Asenbaum S., Vass K., Sauter C., Klösch G., and Kollegger H. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand 10 (2004) 6-13
9. Gottberg K., Einarsson U., Ytterberg C., de Pedro Cuesta J., Fredriksson S., von Koch L., et al. Health-related quality of life in a population-based sample of people with multiple sclerosis. Mult Scler 12 (2006) 605-612
10. Johansson S., Ytterberg C., Claesson I.M., Lindberg J., Hillert J., Andersson M., et al. High concurrent presence of disability in multiple sclerosis: associations with perceived health. J Neurol 254 (2007) 767-773
11. Pfennings L., Cohen L., Adèr H., Polman C., Lankhorst G., Smits R., et al. Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. J Neurol 246 (1999) 587-591
12. Ford H.L., Gerry E., Johnson M.H., and Tennant A. Health status and quality of life of people with multiple sclerosis. Disabil Rehabil 23 (2001) 516-521
13. The International Classification of Functioning. Disability and health (2001), World Health Organization. http://www.who.int/classification/icf Available at: www.who.int/classification/icf Accessed 12 Nov 2007
14. Miller A., and Dishon S. Health-related quality of life in multiple sclerosis: psychometric analysis of inventories. Mult Scler 11 (2005) 450-458
15. Vermersch P., de Seze J., Delisse B., Lemaire S., and Stojkovic T. Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment. Mult Scler 8 (2002) 377-381
16. Freeman J.A., Thompson A.J., Fitzpatrick R., Hutchinson M., Miltenburger C., Beckmann K., et al. Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of life. Neurology 57 (2001) 1870-1875
17. Antonovsky A. The structure and properties of the sense of coherence scale. Soc Sci Med 36 (1993) 725-733
18. Hobart J., Lamping D., Fitzpatrick R., Riazi A., and Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 124 (2001) 962-973
19. Riazi A., Hobart J., Lamping D., Fitzpatrick R., and Thompson A.J. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry 73 (2002) 701-704
20. Hoogervorst E.L., Zwemmer J.N., Jelles B., Polman C.H., and Uitdehaag B.M. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability. Mult Scler 10 (2004) 569-574
21. Hobart J.C., Riazi A., Lamping D.L., Fitzpatrick R., and Thompson A.J. How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales. J Neurol Neurosurg Psychiatry 76 (2005) 1539-1543
22. Costelloe L., O'rourke K., Kearney H., McGuigan C., Gribbin L Duggan M., et al. The patient knows best; significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical). J Neurol Neurosurg Psychiatry 78 (2007) 841-844
23. Patrick D.L., and Deyo R.A. Generic and disease-specific measures in assessing health status and quality of life. Med Care 27 suppl 3 (1989) 217-232
24. O'Connor P., Lee L., Ng P.T., Narayana P., and Wolinsky J.S. Determinants of overall quality of life in secondary progressive MS: a longitudinal study. Neurology 57 (2001) 889-891
25. Riazi A., Thompson A.J., and Hobart J.C. Self-efficacy predicts self-reported health status in multiple sclerosis. Mult Scler 10 (2004) 61-66
26. Ayatollahi P., Nafissi S., Eshraghian M.R., Kaviani H., and Tarazi A. Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis. Mult Scler 13 (2007) 275-277
27. Poser C., Paty D., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13 (1983) 227-231
28. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 77 (1983) 1444-1452
29. Smith A. Symbol Digit Modalities Test (SDMT). In: Lezak M. (Ed). Neuropsychological assessment. 3rd ed (1995), Oxford University Press, New York 379-381
30. Krupp L.B., LaRocca N.G., Muir-Nash J., and Steinberg A.D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46 (1989) 1121-1123
31. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-571
32. Larsson G., and Kallenberg K.O. Sense of coherence, socioeconomic conditions and health. Eur J Public Health 6 (1996) 175-180
33. Bakshi R., Shaikh Z.A., Miletich R.S., Csarnecki D., Dmochowski J., Henschel K., et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 6 (2000) 181-185
34. Goldman Consensus Group. The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler 11 (2005) 328-337
35. The Swedish MS-register. Available at: http://www.msreg.net Accessed 12 Nov 2007.
36. Kazis L.E., Anderson J.J., and Meenan R. Effect sizes for interpreting changes in health status. Med Care 27 suppl 3 (1989) 178-189
37. Cohen J. A power primer. Psychol Bull 112 (1992) 155-159
38. Mathiowetz V.G., Finlayson M.L., Matuska K.M., Chen H.Y., and Luo P. Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Mult Scler 11 (2005) 592-601
39. Thomas P.W., Thomas S., Hillier C., and Galvin K Baker R. Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev Issue 1 (2006)
40. Dent A., and Lincoln N.B. Screening for memory problems in multiple sclerosis. Br J Clin Psychol 39 (2000) 311-315
41. Rudick R., Antel J., Confavreux C., Cutter G., Ellison G., Fischer J., et al. Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol 42 (1997) 379-382
42. Hobart J.C., Riazi A., Lamping D.L., Fitzpatrick R., and Thompson A.J. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess 8 (2004) 1-48